Clinical Trials Logo

Frailty clinical trials

View clinical trials related to Frailty.

Filter by:

NCT ID: NCT04537039 Withdrawn - Frailty Clinical Trials

Home Care Services Screening for Frailty.

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

An improvement in professional practices on the topic of frailty is desirable as much for ambulatory care teams (professionals in home care services) than for hospital care teams (medical and paramedical). Geriatric prevention, screening for frailty, are major challenges for the years to come and require involvement and a know-how. The main hypothesis is that the screening of the frailty of the elderly, by the home care services is relevant and reliable, therefore making it possible to detect a state of frailty and organize preventive care at the earliest. The objectives of this research work are: - to demonstrate that the use of a questionnaire, simple and already validated for a medical use, can be administered by home care services with just as much relevance, - to democratize the detection of frailty by demonstrating that home care services have an important role to play in terms of screening and therefore an equally important impact in terms of public health, - to recall the importance of screening in medical practice, including for the elderly.

NCT ID: NCT04413877 Withdrawn - COVID-19 Clinical Trials

Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE)

ICOPE
Start date: December 1, 2023
Phase:
Study type: Observational [Patient Registry]

Introduction: The World Health Organization has launched the INSPIRE-ICOPE-CARE program towards healthy aging. It includes "intrinsic capacity", defined as "the composite of all the physical and mental capacities of an individual", which has a positive value towards prevention, and is constructed by five domains: cognition, vitality/nutrition, sensory, psychology, and mobility. ICOPE App and ICOPE Monitor are applications for the self-assessment and monitoring of intrinsic capacity. Hypothesis: Intrinsic capacity self-assessed by the ICOPE Apps could be associated with the incidence of frailty and health outcomes. ICOPE Apps might support geriatric and primary care during the COVID-19 pandemic and beyond. Objectives: To assess the association between intrinsic capacity measured by the ICOPE Apps at baseline and the incidence of frailty in community-dwelling older adults during 1-year follow-up. Secondarily, to assess the association of intrinsic capacity and pre-frailty, falls, functional decline, institutionalization, and mortality (COVID-19-related/not related). Methods: Protocol for a cohort study of community-dwelling adults ≥65-year-old, with no other exclusion criteria than the inability to use the Apps or communicate by telephone/video-call for any reason (cognitive or limited access to telephone/video-call). Intrinsic capacity measured by the ICOPE Apps and Rockwood's clinical frailty scale will be assessed at baseline, 4-, 8- and 12-month follow-up by telephone/video-call. Assuming a prevalence of frailty of 10.7%, and incidence of 13% (alpha-risk=0.05), 400 participants at 12-month end-point (relative precision=0.10) and 600 participants at baseline will be required. Associations among the decrease in intrinsic capacity, incidence of frailty, and occurrence of health adverse outcomes during 1-year follow-up are expected. ICOPE Apps might identify individuals at higher risk of frailty and health adverse consequences. The implementation of the ICOPE Apps into clinical practice might help to bring the practitioners closer to their patients, deliver efficient person-centered care-plans, and benefit the healthcare systems during the COVID-19 pandemic and beyond.

NCT ID: NCT04321603 Withdrawn - Hiv Clinical Trials

Altering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65

ALTER
Start date: May 30, 2020
Phase: N/A
Study type: Interventional

People living with HIV are living longer as their disease is controlled with antiretroviral medications. Yet they are experiencing frailty more often and more than ten years earlier than those without HIV. In elderly persons without HIV, frailty is associated with decreased muscle strength and chronic inflammation. Less is known about what is driving early frailty in HIV or effective prevention measures for aging adults with HIV. It may be that having HIV infection impairs energy production by mitochondria within the cells and contributes to the muscle weakness and inflammation accompanying frailty in people living with HIV . This study will examine the impact of six weeks of moderately paced walking on energy production in the cells, inflammation markers and frailty scores in people living with well-controlled HIV who are aged 50 to 65.

NCT ID: NCT04275752 Withdrawn - Kidney Transplant Clinical Trials

Exercise Intervention on Frailty After Kidney Transplantation

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

Researchers are trying to determine if exercise will improve health and strength in kidney transplant patients.

NCT ID: NCT04241159 Withdrawn - Heart Failure Clinical Trials

Study to Explore the Safety and Feasibility of Allogeneic Young Plasma Infusion in Older Adults

Start date: May 2020
Phase: Early Phase 1
Study type: Interventional

Evaluate the feasibility of administering plasma (PF24) acquired from donors of a young chronological age intravenously to older adults at WFBMC while also exploring its effects on age-related functional decline

NCT ID: NCT04223661 Withdrawn - Multiple Myeloma Clinical Trials

Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy

Start date: December 6, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if using a subject's baseline frailty score to guide the dosing of lenalidomide in a combination with dexamethasone and daratumumab (DRd lite).

NCT ID: NCT04200846 Withdrawn - Frailty Clinical Trials

Frailty in Liver Transplant Exercise (FLEX) Trial

FLEX
Start date: July 1, 2021
Phase: N/A
Study type: Interventional

Frailty is common in patients with end-stage liver disease. It's characterized by reduced strength, low endurance and reduced physical function. While exercise intervention can improve frailty in geriatric patients without liver disease, whether or not exercise intervention can improve frailty in liver transplant candidates remains unknown.

NCT ID: NCT04052672 Withdrawn - Clinical trials for Cardiovascular Diseases

Diet and Exercise Frailty Intervention in Cardiac Device Patients

DEFINIT-P
Start date: November 1, 2019
Phase: N/A
Study type: Interventional

DEFINIT-P is a prospective pilot study of frailty in cardiac device recipients, comprised of a registry and randomized control trial. The RCT is a supervised exercise program and nutritional supplement intervention for pre-frail and frail cardiac device participants. The registry will be used to describe all cardiac device recipients, regardless of frailty status.

NCT ID: NCT04044846 Withdrawn - Frailty Clinical Trials

Promoting Movement in Older Adults in the Community

(ProMO)
Start date: October 7, 2020
Phase: N/A
Study type: Interventional

It is well known that exercise is great medicine, however, for frail older adults who are often homebound and require assistance with personal care, there are gaps in both prescribing this "medicine" and in filling the prescription. The investigators will uncover and address the barriers that prevent frail older adults from increasing their level of physical activity. With input from frail older adults, caregivers, and healthcare providers, the investigators will create a free, easy to use, home-based program that incorporates physical activity such as gentle stretches and range of motion exercises when personal care is being provided. This innovation will add great value to the type of care that is being provided to homebound frail older adults. Incorporating physical activity as part of the care provided offers a unique opportunity for homebound frail older adults to move more, and improve their well-being.

NCT ID: NCT04012333 Withdrawn - Critical Illness Clinical Trials

The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial

EFFORTcombo
Start date: June 2020
Phase: Phase 3
Study type: Interventional

The primary research question: In critically ill patients with nutrition 'risk factors', what is the effect of providing combined EN/PN to the group prescribed a higher dose (≥2.2 grams/kg/day) of protein/amino acid administration compared to a low group prescribed ≤1.2 gram/kg/day (EN only) on patient's functional recovery as measured by 6-minute walk distance just prior to hospital discharge? The hypothesis: Compared to a control group reflective of usual care prescribing practices and an EN only approach, the administration of a higher dose protein/amino acids using EN and PN to nutritionally high-risk critically ill patients will be associated with improved functional outcome.